Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Recruiting · NCT06839235 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperoxaluria, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, kidney disorder, metabolic disease, primary hyperoxaluria, primary hyperoxaluria type 1, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-02-12 | NCT06839235 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arbor Biotechnologies | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Heidi Chaker | Sfax | Tunisia | 1 |
| Hospices Civils de Lyon- Hôpital Femmes Mères Enfants | Lyon | France | 1 |
| Kindernierenzentrum Bonn | Bonn | Germany | 1 |
| Mayo Clinic | Rochester | United States | 664 |
| Nucleus Network | Saint Paul | United States | 5 |
| Queen Elizabeth Hospital Birmingham | Birmingham | United Kingdom | 10 |
| Royal Free Hospital | London | United Kingdom | 24 |